Hims & Hers Health, Inc.(HIMS)NASDAQ
Company Profile & Information
Company Profile
Business overview, scale, and footprint
Business Overview
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Insider Transactions
Open-market activity and option exercises
Insider Activity Summary
Insider trading activity for Hims & Hers Health, Inc. (HIMS) over the last 3 months consists of 170 total transactions. Among these, company executives and board members conducted 170 buys (totaling 13,922,930 shares) and 0 sells (totaling 0 shares). This activity resulted in a net change of 13,922,930 shares, reflecting net buying interest with an estimated net acquisitions value of $7.64B.
170 insider transactions found. Showing 10 of 170 transactions.
| Insider Name | Relation to Company | Shares Changed | Price | Transaction Date |
|---|---|---|---|---|
| OKUPE OLUYEMI | Chief Financial Officer | 4,938 | $24739.00 | Aug 19, 2026 |
| BOUGHTON SOLEIL | Officer | 25,111 | $0.69 | Aug 19, 2026 |
| AUTOR DEBORAH M | Officer and Director | 16,773 | $0.47 | Aug 18, 2026 |
| OKUPE OLUYEMI | Chief Financial Officer | 81,004 | $47034.00 | Aug 17, 2026 |
| OKUPE OLUYEMI | Chief Financial Officer | 64,771 | $2.21 | Aug 17, 2026 |
| WELLS DAVID B | Director | 778 | $N/A | Aug 14, 2026 |
| PAYNE CHRISTOPHER D | Director | 545 | $N/A | Aug 14, 2026 |
| SCHULTZ KARE | Director | 6,623 | $N/A | Aug 14, 2026 |
| DUDUM ANDREW | Chief Executive Officer | 154,993 | $N/A | Aug 14, 2026 |
| BECKLUND IRENE | Officer | 13,685 | $N/A | Aug 14, 2026 |
Explore More Analysis for HIMS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.